747-302

Sponsor: Intercept

Principal Investigator: Paul J. Thuluvath, M.D., FRCP, 410-332-9356

Research Coordinator: Olivia Tang, 410-843-2069

For More Information: otang@mdmercy.com

Coordinated Through: The Institute for Digestive Health and Liver Disease

This study is a phase 4 trial evaluating the effect of obeticholic acid on clinical outcomes in patients with primary biliary cholangitis. (302)